Effectiveness of intervention program on the change of glycaemic control in diabetes with depression patients: A meta-analysis of randomized controlled studies

Lu, Xiaobing; Yang, Dongying; Liang, Jiaquan; Xie, Guojun; Li, Xuesong; Xu, Caixia; Liao, Hairong; Zhou, Hui; Xu, Zhenyu; Ye, Chan; Chen, Hạixia; Liang, Meihong; Shen, Qi; Sun, Ting; Hu, Yutong; Zhang, Weizhi; Ning, Yuping

doi:10.1016/j.pcd.2021.01.006

Cited by 10 publications

(7 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our study, the post-test scores re ect that CBT effectively helped the patients develop a positive attitude toward life by defeating the negative attitude that helping the patients to decline their depression to a great extent [42,43].Our data support that CBT is an effective intervention and can be used as a treatment approach for managing Depression among T2DM [40]. Depression is ubiquitous that affects patients with diabetes.…”

Section: Discussionsupporting

confidence: 58%

Cognitive Behavior Therapy for Diabetes Distress, Depression, Health Anxiety, Quality of life and Treatment Adherence among patients with Type- II Diabetes Mellitus: A Randomized Control Trial

Abbas

Latif

Habib

et al. 2022

Preprint

View full text Add to dashboard Cite

Objective Diabetes distress typically causes depression common comorbidity of diabetes unpleasantly affects patients' medical and mental functions. Psychotherapeutic interventions are effective treatments to treat depressive disorders and improve the quality of life in chronic diseases as well as in patients with diabetes. The present study aimed to investigate the efficacy of cognitive behavior therapy (CBT) with experimental and waitlist control conditions to treat depression in patients with type 2 diabetes mellitus (T2DM). Materials and Methods A total of 130 outpatients with diabetes and depression were assessed in this randomized control trial and 90 patients were randomized to CBT with experimental (n = 45) and waitlist control (n = 45) conditions. All the patients completed clinical interviews and assessment measures at pre-and post-assessment 16 weeks intervals. Diabetes Distress Scale (DDS) and Patient Health Questionnaire (PHQ) were used to assess primary outcomes. Short Health Anxiety Inventory (SHAI), Revised Version of Diabetes Quality of Life Questionnaire (DQLQ), and General Medication Adherence Scale (GMAS) were used to investigate secondary outcomes. Results The findings indicated that patients received CBT significantly decreased the level of diabetes distress F(1,60) = 222.710, P < 0.001, η2 = .788), depression F(1,60) = 94.436, P < 0.001, η2 = .611), health anxiety F(1,60) = 201.915, P < .0.001, η2 = 771) as compared to waitlist control condition. Moreover, participants received CBT significantly improved the quality of life F(1,60) = 83.352, P < 0.001, η2 = .581), treatment adherence F(1,60) = 67.579, P < 0.001, η2 = .566) and physical activity schedule F(1,60) = 164.245, P < .0.001, η2 = .736 as compared to a waitlist control condition. Conclusion It is concluded that cognitive behavior therapy is an effective and promising intervention for depressive symptoms, diabetes distress, and health anxiety which also help the person to promote quality of life, treatment adherence and physical activity.

show abstract

Section: Discussionsupporting

confidence: 58%

Cognitive Behavior Therapy for Diabetes Distress, Depression, Health Anxiety, Quality of life and Treatment Adherence among patients with Type- II Diabetes Mellitus: A Randomized Control Trial

Abbas

Latif

Habib

et al. 2022

Preprint

View full text Add to dashboard Cite

show abstract

“…Trials have shown consistent evidence of improvements in depressive symptoms and variable benefits for A1C when depression is simultaneously treated (331,392,394), whether through pharmacological treatment, group therapy, psychotherapy, or collaborative care (328,348,349,395,396). Psychological interventions targeting depressive symptoms have shown efficacy when delivered via digital technologies (397).…”

Section: Psychological Assessment and Treatmentmentioning

confidence: 99%

5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes:Standards of Care in Diabetes—2023

ElSayed¹,

Aleppo²,

Aroda³

et al. 2022

Diabetes Care

235

View full text Add to dashboard Cite

The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

show abstract

“…Moreover, the analysis reveals that CBT effectively helped the patients to develop a positive attitude toward life and promoted their functional outcomes through skill training [43,44]. This reflects that CBT is an effective intervention to address depressive symptoms among T2DM [41].…”

Section: Discussionmentioning

confidence: 99%

Cognitive behavior therapy for diabetes distress, depression, health anxiety, quality of life and treatment adherence among patients with type-II diabetes mellitus: a randomized control trial

et al. 2023

View full text Add to dashboard Cite

Objective Diabetes distress typically causes depressive symptoms; common comorbidity of diabetes unpleasantly affects patients’ medical and psychological functions. Psychotherapeutic interventions are effective treatments to treat depressive symptoms and to improve the quality of life in many chronic diseases including diabetes. The present study investigated the efficacy of cognitive behavior therapy (CBT) to treat depressive symptoms in patients with type 2 diabetes mellitus (T2DM) using experimental and waitlist control conditions. Materials and Methods A total of 130 diagnosed patients with T2DM were taken from outdoor patients services of different hospitals in Faisalabad. Ninety patients met the eligibility criteria and were randomly assigned to experimental (n = 45) and waitlist control (n = 45) conditions. All the patients completed clinical interviews and assessment measures at pre-and post-assessment stages (16 weeks intervals). Medical consultants at the respective hospitals diagnosed the patients on the base of their medical reports and then referred those patients to us. Then we used different scales to assess primary and secondary outcomes: Diabetes Distress Scale (DDS) and Patient Health Questionnaire (PHQ) to assess primary outcomes, and a Short Health Anxiety Inventory (SHAI), a Revised Version of the Diabetes Quality of Life Questionnaire (DQLQ), and a General Medication Adherence Scale (GMAS) were used to investigate secondary outcomes. Repeated measure ANOVA was used to analyze the results. Results The findings indicated that patients who received CBT got a significant reduction in their diabetes distress F(1,60) = 222.710, P < 0.001, η2 = .788), depressive symptoms F(1,60) = 94.436, P < 0.001, η2 = .611), health anxiety F(1,60) = 201.915, P < .0.001, η2 = 771), and a significant improvement in their quality of life F(1,60) = 83.352, P < 0.001, η2 = .581), treatment adherence F(1,60) = 67.579, P < 0.001, η2 = .566) and physical activity schedule F(1,60) = 164.245, P < .0.001, η2 = .736 as compared to the patients in waitlist control condition. Conclusion It is concluded that cognitive behavior therapy is an effective and promising intervention for depressive symptoms, diabetes distress, and health anxiety which also helps the person to promote quality of life, treatment adherence and physical activity.

show abstract

Effectiveness of intervention program on the change of glycaemic control in diabetes with depression patients: A meta-analysis of randomized controlled studies

Cited by 10 publications

References 28 publications

Cognitive Behavior Therapy for Diabetes Distress, Depression, Health Anxiety, Quality of life and Treatment Adherence among patients with Type- II Diabetes Mellitus: A Randomized Control Trial

Cognitive Behavior Therapy for Diabetes Distress, Depression, Health Anxiety, Quality of life and Treatment Adherence among patients with Type- II Diabetes Mellitus: A Randomized Control Trial

5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes:Standards of Care in Diabetes—2023

Cognitive behavior therapy for diabetes distress, depression, health anxiety, quality of life and treatment adherence among patients with type-II diabetes mellitus: a randomized control trial

Contact Info

Product

Resources

About